Lee Hyun Woo, Ryu Hyung Won, Kang Myung-Gyun, Park Daeui, Lee Hanna, Shin Heung Mook, Oh Sei-Ryang, Kim Hoon
Department of Pharmacy and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea.
Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, 30 Yeongudanji-ro, Ochang-eup, Cheongju, Chungbuk 28116, Republic of Korea.
Int J Biol Macromol. 2017 Apr;97:598-605. doi: 10.1016/j.ijbiomac.2017.01.080. Epub 2017 Jan 18.
During the ongoing search for new monoamine oxidase (MAO) inhibitors, five coumarin derivatives and eight flavonoids were isolated from the roots of Angelica gigas Nakai and Scutellaria baicalensis Georgi, respectively. Of the phytochemicals, decursin (4) was found to potently and selectively inhibit human MAO-A (IC=1.89μM). The IC value of 4 for MAO-A belonged to the lowest group in herbal sources and was similar to that of toloxatone (1.78μM), a marketed drug. Wogonin (11) effectively inhibited MAO-A and MAO-B (IC=6.35 and 20.8μM, respectively). Furthermore, compounds 5 (decursinol angelate) and 10 (baicalein) were observed to selectively and moderately inhibit MAO-A. In addition, compound 4 reversibly and competitively inhibited MAO-A with a K of 0.17μM. Compound 11 also competitively inhibited MAO-A and MAO-B (K=0.56 and 1.96μM, respectively). Molecular docking simulation revealed that 4 interacts with Asn181 residue of MAO-A or Asn116 residue of MAO-B by formation of hydrogen bond. The findings suggest compounds 4 and 11 be considered as new potent and reversible MAO-A inhibitors or useful lead compounds for the developments of MAO inhibitors for the treatment of disorders like depression, Parkinson's disease and Alzheimer disease.
在持续寻找新型单胺氧化酶(MAO)抑制剂的过程中,分别从当归和黄芩的根部分离出了5种香豆素衍生物和8种黄酮类化合物。在这些植物化学物质中,发现紫花前胡醇(4)能有效且选择性地抑制人MAO - A(IC = 1.89μM)。4对MAO - A的IC值在草药来源中属于最低组,与市售药物托洛沙酮(1.78μM)相似。汉黄芩素(11)能有效抑制MAO - A和MAO - B(IC分别为6.35和20.8μM)。此外,观察到化合物5(紫花前胡醇当归酸酯)和10(黄芩素)能选择性且适度地抑制MAO - A。另外,化合物4以0.17μM的K值可逆且竞争性地抑制MAO - A。化合物11也竞争性地抑制MAO - A和MAO - B(K分别为0.56和1.96μM)。分子对接模拟显示,4通过形成氢键与MAO - A的Asn181残基或MAO - B的Asn116残基相互作用。这些发现表明化合物4和11可被视为新型强效且可逆的MAO - A抑制剂,或作为开发用于治疗抑郁症、帕金森病和阿尔茨海默病等疾病的MAO抑制剂的有用先导化合物。